Los Angeles Capital Management’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-17,313
| Closed | -$175K | – | 1207 |
|
|
2022
Q4 | $175K | Sell |
17,313
-1,515
| -8% | -$15.3K | ﹤0.01% | 1149 |
|
|
2022
Q3 | $422K | Buy |
18,828
+1,247
| +7% | +$28K | ﹤0.01% | 970 |
|
|
2022
Q2 | $436K | Buy |
17,581
+601
| +4% | +$14.9K | ﹤0.01% | 1013 |
|
|
2022
Q1 | $658K | Sell |
16,980
-747
| -4% | -$28.9K | ﹤0.01% | 923 |
|
|
2021
Q4 | $1.04M | Buy |
17,727
+142
| +0.8% | +$8.31K | ﹤0.01% | 720 |
|
|
2021
Q3 | $1.04M | Hold |
17,585
| – | – | ﹤0.01% | 751 |
|
|
2021
Q2 | $1.53M | Sell |
17,585
-1,780
| -9% | -$154K | 0.01% | 673 |
|
|
2021
Q1 | $1.6M | Sell |
19,365
-11,433
| -37% | -$943K | 0.01% | 694 |
|
|
2020
Q4 | $2.8M | Buy |
30,798
+340
| +1% | +$30.9K | 0.01% | 554 |
|
|
2020
Q3 | $1.22M | Buy |
30,458
+1,375
| +5% | +$54.9K | 0.01% | 740 |
|
|
2020
Q2 | $998K | Buy |
29,083
+3,591
| +14% | +$123K | ﹤0.01% | 852 |
|
|
2020
Q1 | $566K | Buy |
+25,492
| New | +$566K | ﹤0.01% | 867 |
|